Pharmaceuticals Oxytocic Pharmaceuticals Market For...

Oxytocic Pharmaceuticals Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product (Natural Oxytocin, Synthetic Oxytocin); Route of Administration (Intramuscular Injection, Intravenous Infusion, Others); Application (Pre-Eclampsia, Postpartum Hemorrhage, Others); End User (Hospitals, Maternity Clinics); and Geography

Report Code: TIPRE00006930 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Oxytocic is a hormone which is used for inducing labor or strengthen uterine contractions. This drug is also used to control bleeding after childbirth. In some cases the drug is used to stimulate uterine contractions in a woman with an incomplete or threatened miscarriage. The drug is injected into a muscle or it can be infused into a vein. However, the technological development has resulted various other forms of drug.

MARKET DYNAMICS

The oxytocic pharmaceuticals market is anticipated to grow in the forecast, owing to the factors such as rising cases of hospital delivery, increasing number of caesarian procedures, and growing number of pregnancy-related complications, expansion of the health care and pharmaceutical industry and growing incidences of preterm births. The market is expected to have growth opportunities due to rising numbers of birth rate during the forecast period.

MARKET SCOPE

The "Global Oxytocic Pharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of oxytocic pharmaceuticals market with detailed market segmentation by product, route of administration, application, end user and geography. The global oxytocic pharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading oxytocic pharmaceuticals market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global oxytocic pharmaceuticals market is segmented on the basis of product, route of administration, application and end user. Based on product the market is classified as natural oxytocin, and synthetic oxytocin. On the basis of route of administration the market is segmented as intramuscular injection, intravenous infusion, and others. Based on application the market is segmented as pre-eclampsia, postpartum hemorrhage, and others. And on the basis of end user the market is segmented as hospitals, and maternity clinics.



Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global oxytocic pharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oxytocic pharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting oxytocic pharmaceuticals market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oxytocic pharmaceuticals market in these regions.



Get more information on this report :

MARKET PLAYERS

The reports cover key developments in the oxytocic pharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from oxytocic pharmaceuticals market are anticipated to lucrative growth opportunities in the future with the rising demand for oxytocic pharmaceuticals market in the global market. Below mentioned is the list of few companies engaged in the oxytocic pharmaceuticals market.

The report also includes the profiles of oxytocic pharmaceuticals market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  Fresenius Kabi Canada
  •  Teva Pharmaceutical Industries
  •  Novartis Pharmaceuticals Corporation.
  •  Baxter Healthcare
  •  APP Pharmaceuticals, LLC
  •  JHP Pharmaceuticals, LLC
  •  Hikma Pharmaceuticals PLC
  •  Par Sterile Products, LLC
  •  Janssen Pharmaceutica N.V (Johnson and Johnson Services Inc.)
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oxytocic Pharmaceuticals Market - By Product
1.3.2 Oxytocic Pharmaceuticals Market - By Route of Administration
1.3.3 Oxytocic Pharmaceuticals Market - By Application
1.3.4 Oxytocic Pharmaceuticals Market - By End User
1.3.5 Oxytocic Pharmaceuticals Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. OXYTOCIC PHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. OXYTOCIC PHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. OXYTOCIC PHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. OXYTOCIC PHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. OXYTOCIC PHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. OXYTOCIC PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. NATURAL OXYTOCIN
7.3.1. Overview
7.3.2. Natural Oxytocin Market Forecast and Analysis
7.4. SYNTHETIC OXYTOCIN
7.4.1. Overview
7.4.2. Synthetic Oxytocin Market Forecast and Analysis

8. OXYTOCIC PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAMUSCULAR INJECTION
8.3.1. Overview
8.3.2. Intramuscular Injection Market Forecast and Analysis
8.4. INTRAVENOUS INFUSION
8.4.1. Overview
8.4.2. Intravenous Infusion Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. OXYTOCIC PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PRE-ECLAMPSIA
9.3.1. Overview
9.3.2. Pre-Eclampsia Market Forecast and Analysis
9.4. POSTPARTUM HEMORRHAGE
9.4.1. Overview
9.4.2. Postpartum Hemorrhage Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. OXYTOCIC PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. MATERINITY CLINICS
10.4.1. Overview
10.4.2. Maternity Clinics Market Forecast and Analysis

11. OXYTOCIC PHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Oxytocic Pharmaceuticals Market Overview
11.1.2 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis
11.1.3 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Product
11.1.4 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
11.1.5 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Application
11.1.6 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By End User
11.1.7 North America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Countries
11.1.7.1 United States Oxytocic Pharmaceuticals Market
11.1.7.1.1 United States Oxytocic Pharmaceuticals Market by Product
11.1.7.1.2 United States Oxytocic Pharmaceuticals Market by Route of Administration
11.1.7.1.3 United States Oxytocic Pharmaceuticals Market by Application
11.1.7.1.4 United States Oxytocic Pharmaceuticals Market by End User
11.1.7.2 Canada Oxytocic Pharmaceuticals Market
11.1.7.2.1 Canada Oxytocic Pharmaceuticals Market by Product
11.1.7.2.2 Canada Oxytocic Pharmaceuticals Market by Route of Administration
11.1.7.2.3 Canada Oxytocic Pharmaceuticals Market by Application
11.1.7.2.4 Canada Oxytocic Pharmaceuticals Market by End User
11.1.7.3 Mexico Oxytocic Pharmaceuticals Market
11.1.7.3.1 Mexico Oxytocic Pharmaceuticals Market by Product
11.1.7.3.2 Mexico Oxytocic Pharmaceuticals Market by Route of Administration
11.1.7.3.3 Mexico Oxytocic Pharmaceuticals Market by Application
11.1.7.3.4 Mexico Oxytocic Pharmaceuticals Market by End User
11.2. EUROPE
11.2.1 Europe Oxytocic Pharmaceuticals Market Overview
11.2.2 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis
11.2.3 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Product
11.2.4 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
11.2.5 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Application
11.2.6 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis - By End User
11.2.7 Europe Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Oxytocic Pharmaceuticals Market
11.2.7.1.1 Germany Oxytocic Pharmaceuticals Market by Product
11.2.7.1.2 Germany Oxytocic Pharmaceuticals Market by Route of Administration
11.2.7.1.3 Germany Oxytocic Pharmaceuticals Market by Application
11.2.7.1.4 Germany Oxytocic Pharmaceuticals Market by End User
11.2.7.2 France Oxytocic Pharmaceuticals Market
11.2.7.2.1 France Oxytocic Pharmaceuticals Market by Product
11.2.7.2.2 France Oxytocic Pharmaceuticals Market by Route of Administration
11.2.7.2.3 France Oxytocic Pharmaceuticals Market by Application
11.2.7.2.4 France Oxytocic Pharmaceuticals Market by End User
11.2.7.3 Italy Oxytocic Pharmaceuticals Market
11.2.7.3.1 Italy Oxytocic Pharmaceuticals Market by Product
11.2.7.3.2 Italy Oxytocic Pharmaceuticals Market by Route of Administration
11.2.7.3.3 Italy Oxytocic Pharmaceuticals Market by Application
11.2.7.3.4 Italy Oxytocic Pharmaceuticals Market by End User
11.2.7.4 Spain Oxytocic Pharmaceuticals Market
11.2.7.4.1 Spain Oxytocic Pharmaceuticals Market by Product
11.2.7.4.2 Spain Oxytocic Pharmaceuticals Market by Route of Administration
11.2.7.4.3 Spain Oxytocic Pharmaceuticals Market by Application
11.2.7.4.4 Spain Oxytocic Pharmaceuticals Market by End User
11.2.7.5 United Kingdom Oxytocic Pharmaceuticals Market
11.2.7.5.1 United Kingdom Oxytocic Pharmaceuticals Market by Product
11.2.7.5.2 United Kingdom Oxytocic Pharmaceuticals Market by Route of Administration
11.2.7.5.3 United Kingdom Oxytocic Pharmaceuticals Market by Application
11.2.7.5.4 United Kingdom Oxytocic Pharmaceuticals Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Oxytocic Pharmaceuticals Market Overview
11.3.2 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis
11.3.3 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
11.3.5 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Oxytocic Pharmaceuticals Market
11.3.7.1.1 Australia Oxytocic Pharmaceuticals Market by Product
11.3.7.1.2 Australia Oxytocic Pharmaceuticals Market by Route of Administration
11.3.7.1.3 Australia Oxytocic Pharmaceuticals Market by Application
11.3.7.1.4 Australia Oxytocic Pharmaceuticals Market by End User
11.3.7.2 China Oxytocic Pharmaceuticals Market
11.3.7.2.1 China Oxytocic Pharmaceuticals Market by Product
11.3.7.2.2 China Oxytocic Pharmaceuticals Market by Route of Administration
11.3.7.2.3 China Oxytocic Pharmaceuticals Market by Application
11.3.7.2.4 China Oxytocic Pharmaceuticals Market by End User
11.3.7.3 India Oxytocic Pharmaceuticals Market
11.3.7.3.1 India Oxytocic Pharmaceuticals Market by Product
11.3.7.3.2 India Oxytocic Pharmaceuticals Market by Route of Administration
11.3.7.3.3 India Oxytocic Pharmaceuticals Market by Application
11.3.7.3.4 India Oxytocic Pharmaceuticals Market by End User
11.3.7.4 Japan Oxytocic Pharmaceuticals Market
11.3.7.4.1 Japan Oxytocic Pharmaceuticals Market by Product
11.3.7.4.2 Japan Oxytocic Pharmaceuticals Market by Route of Administration
11.3.7.4.3 Japan Oxytocic Pharmaceuticals Market by Application
11.3.7.4.4 Japan Oxytocic Pharmaceuticals Market by End User
11.3.7.5 South Korea Oxytocic Pharmaceuticals Market
11.3.7.5.1 South Korea Oxytocic Pharmaceuticals Market by Product
11.3.7.5.2 South Korea Oxytocic Pharmaceuticals Market by Route of Administration
11.3.7.5.3 South Korea Oxytocic Pharmaceuticals Market by Application
11.3.7.5.4 South Korea Oxytocic Pharmaceuticals Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Oxytocic Pharmaceuticals Market Overview
11.4.2 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis
11.4.3 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
11.4.5 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Oxytocic Pharmaceuticals Market
11.4.7.1.1 South Africa Oxytocic Pharmaceuticals Market by Product
11.4.7.1.2 South Africa Oxytocic Pharmaceuticals Market by Route of Administration
11.4.7.1.3 South Africa Oxytocic Pharmaceuticals Market by Application
11.4.7.1.4 South Africa Oxytocic Pharmaceuticals Market by End User
11.4.7.2 Saudi Arabia Oxytocic Pharmaceuticals Market
11.4.7.2.1 Saudi Arabia Oxytocic Pharmaceuticals Market by Product
11.4.7.2.2 Saudi Arabia Oxytocic Pharmaceuticals Market by Route of Administration
11.4.7.2.3 Saudi Arabia Oxytocic Pharmaceuticals Market by Application
11.4.7.2.4 Saudi Arabia Oxytocic Pharmaceuticals Market by End User
11.4.7.3 U.A.E Oxytocic Pharmaceuticals Market
11.4.7.3.1 U.A.E Oxytocic Pharmaceuticals Market by Product
11.4.7.3.2 U.A.E Oxytocic Pharmaceuticals Market by Route of Administration
11.4.7.3.3 U.A.E Oxytocic Pharmaceuticals Market by Application
11.4.7.3.4 U.A.E Oxytocic Pharmaceuticals Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Oxytocic Pharmaceuticals Market Overview
11.5.2 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis
11.5.3 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Product
11.5.4 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
11.5.5 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Application
11.5.6 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By End User
11.5.7 South and Central America Oxytocic Pharmaceuticals Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Oxytocic Pharmaceuticals Market
11.5.7.1.1 Brazil Oxytocic Pharmaceuticals Market by Product
11.5.7.1.2 Brazil Oxytocic Pharmaceuticals Market by Route of Administration
11.5.7.1.3 Brazil Oxytocic Pharmaceuticals Market by Application
11.5.7.1.4 Brazil Oxytocic Pharmaceuticals Market by End User
11.5.7.2 Argentina Oxytocic Pharmaceuticals Market
11.5.7.2.1 Argentina Oxytocic Pharmaceuticals Market by Product
11.5.7.2.2 Argentina Oxytocic Pharmaceuticals Market by Route of Administration
11.5.7.2.3 Argentina Oxytocic Pharmaceuticals Market by Application
11.5.7.2.4 Argentina Oxytocic Pharmaceuticals Market by End User

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. OXYTOCIC PHARMACEUTICALS MARKET, KEY COMPANY PROFILES
13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. FRESENIUS KABI CANADA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TEVA PHARMACEUTICAL INDUSTRIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS PHARMACEUTICALS CORPORATION.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BAXTER HEALTHCARE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. APP PHARMACEUTICALS, LLC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JHP PHARMACEUTICALS, LLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HIKMA PHARMACEUTICALS PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PAR STERILE PRODUCTS, LLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. JANSSEN PHARMACEUTICA N.V (JOHNSON AND JOHNSON SERVICES INC.)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Fresenius Kabi Canada
3. Teva Pharmaceutical Industries
4. Novartis Pharmaceuticals Corporation.
5. Baxter Healthcare
6. APP Pharmaceuticals, LLC
7. JHP Pharmaceuticals, LLC
8. Hikma Pharmaceuticals PLC
9. Par Sterile Products, LLC
10. Janssen Pharmaceutica N.V (Johnson and Johnson Services Inc.)
TIPRE00006930
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved